Effect of ARHI on lung cancer cell proliferation, apoptosis and invasion in vitro

Molecular Biology Reports

Volumn 40, Issue 3, 2013, Pages 2671-2678

  Wu, Xiaohong ^a   Liang, Li ^a,c   Dong, Liangliang ^a   Yu, Zhe ^b   Fu, Xiaoqing ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b Hangzhou 6th People's Hospital   (China)

^c Hangzhou Xiasha Hospital   (China)

Author keywords

ARHI; Cyclin D1; Lung cancer; MMP 1; MMP 2

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; GELATINASE A; INTERSTITIAL COLLAGENASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARHI GENE; ARTICLE; CANCER CELL; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; LUNG CANCER; NUCLEOTIDE SEQUENCE; TUMOR SUPPRESSOR GENE; UPREGULATION;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DEATH-ASSOCIATED PROTEIN KINASES; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; RHO GTP-BINDING PROTEINS;

APLYSIA; EUKARYOTA;

EID: 84878392716     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2353-x     Document Type: Article

References (24)

1. Badgwell DB, Lu Z, Le K, Gao F, Yang M, Suh GK, Bao JJ, Das P, Andreeff M, Chen W, Yu Y, Ahmed AA, SLL W, Bast RC Jr (2012) The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways. Oncogene 31:68-79
2. Prager GW, Poettler M, Unseld M, Zielinski CC (2012) Angiogenesis in cancer: anti-VEGF escape mechanisms. Transl Lung Cancer Res 1:14-25
3. Zou CF, Jia L, Jin H, Yao M, Zhao N, Huan J, Lu Z, Bast RC Jr, Feng Y, Yu Y (2011) Re-expression of ARHI (DIRAS3) induces autophagy in breast cancer cells and enhances the inhibitory effect of paclitaxel. BMC Cancer 11:22
4. Shadfan M, Lopez-Pajares V, Yuan ZM (2012) MDM2 and MDMX: alone and together in regulation of p53. Transl Cancer Res 1:88-99
5. Luo RZ, Fang X, Marquez R, Liu SY, Mills GB, Liao WS, Yu Y, Bast RC (2003) ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers. Oncogene 22:2897-2909
6. Méndez M, Custodio A, Provencio M (2011) New molecular targeted therapies for advanced non-small-cell lung cancer. J Thorac Dis 3:30-56
7. Rosen DG, Wang L, Jain AN, Lu KH, Luo RZ, Yu Y, Liu J, Bast RC Jr (2004) Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival. Clin Cancer Res 10:6559-6566
8. Li Y, Shi L, Han C, Wang Y, Yang J, Cao C, Jiao S (2012) Effects of ARHI on cell cycle progression and apoptosis levels of breast cancer cells. Tumour Biol 33:1403-1410
9. Nurunnabi M, Khatun Z, Moon WC, Lee G, Lee YK (2012) Heparin based nanoparticles for cancer targeting and noninvasive imaging. Quant Imaging Med Surg 2:219-226
10. Field JK, Liloglou T, Warrak S, Burger M, Becker E, Berlin K, Nimmrich I, Maier S (2005) Methylation discriminators in NSCLC identified by a microarray based approach. Int J Oncol 27:105-111
11. Yang H, Lu X, Qian J, Xu F, Hu Y, Yu Y, Bast RC, Li J (2010) Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells. Mol Med Rep 3:581-587
12. Waltering KK, Helenius MA, Sahu B, Manni V, Linja MJ, Janne OA, Visakorpi T (2009) Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens. Cancer Res 69:8141-8149
13. Lu X, Qian J, Yu Y, Yang H, Li J (2009) Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest. Oncol Rep 22:635-640
14. Lin D, Cui F, Bu Q, Yan C (2011) The expression and clinical significance of GTP-binding RAS-like 3 (ARHI) and microRNA 221 and 222 in prostate Cancer. J Int Med Res 39:1870-1875
15. Chen MY, Liao WS, Lu Z, Bornmann WG, Hennessey V, Washington MN, Rosner GL, Yu Y, Ahmed AA, Bast RC Jr (2011) Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy. Cancer 117:4424-4438
16. Zhao X, Li J, Zhuo J, Cai L (2010) Reexpression of ARHI inhibits tumor growth and angiogenesis and impairs the mTOR/VEGF pathway in hepatocellular carcinoma. Biochem Biophys Res Commun 403:417-421
17. Peng H, Xu F, Pershad R, Hunt KK, Frazier ML, Berchuck A, Gray JW, Hogg D, Bast RC Jr, Yu Y (2000) ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers. Int J Cancer 86:690-694
18. Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S, Kondo S, Kondo Y, Yu Y, Mills GB, Liao WS, Bast RC Jr (2008) The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Investig 118:3917-3929
19. Xu C, Hao Y, Wei B, Ma J, Li J, Huang Q, Zhang F (2011) Apoptotic gene expression by human periodontal ligament cells following cyclic stretch. J Periodontal Res 46:742-748
20. Aberg M, Johnell M, Wickstrom M, Siegbahn A (2011) Tissue Factor/FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1). Thromb Res 127:141-148
21. Carter CJ (2008) Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades. Neurochem Int 52:920-934
22. Wong JC, Chan SK, Schaeffer DF, Sagaert X, Lim HJ, Kennecke H, Owen DA, Suh KW, Kim YB, Tai IT (2011) Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer. Clin Cancer Res 17:4167-4176
23. Jeffery N, McLean MH, El-Omar EM, Murray GI (2009) The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers. Histopathology 54:820-828
24. Pritchard SC, Nicolson MC, Lloret C, McKay JA, Ross VG, Kerr KM, Murray GI, McLeod HL (2001) Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: implications for MMP inhibition therapy. Oncol Rep 8:421-424